STOCK TITAN

Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million

(Neutral)
(Neutral)
Tags
private placement

Vanta (OTC:VNTXF) closed the second tranche of a non‑brokered private placement on May 6, 2026, issuing 615,000 units at $1.00 per unit for gross proceeds of $615,000, bringing aggregate raises to $1,000,000.

Each Unit includes one common share and one warrant exercisable at $1.25 until May 6, 2028. Net proceeds are intended for payables (including related parties), corporate awareness, inventory, and working capital. Securities are subject to a statutory hold expiring September 7, 2026.

Loading...
Loading translation...

Positive

  • Raised aggregate gross proceeds of $1,000,000
  • Second tranche delivered $615,000 in immediate liquidity
  • Proceeds earmarked for payables, inventory, and working capital

Negative

  • Issuance of 615,000 shares plus warrants may cause dilution
  • Warrants exercisable at $1.25 through May 6, 2028 could increase share count
  • Securities subject to statutory hold until September 7, 2026

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium hydration and longevity brand, announces that, further to its news release dated May 5, 2026, the Company has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Private Placement").

Under the Second Tranche, the Company issued 615,000 units (each, a "Unit") at a price of $1.00 per Unit, for aggregate gross proceeds of $615,000. Each Unit consists of one common share in the capital of the Company (each, a "Share") and one transferable common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to acquire one additional Share (each, a "Warrant Share") at an exercise price of $1.25 per Warrant Share until May 6, 2028.

The closing of the Second Tranche, together with the previously announced closing of the first tranche on May 5, 2026, brings the aggregate gross proceeds of the Private Placement to $1,000,000.

The net proceeds of the Private Placement are intended to be allocated towards the payment of outstanding and future payables and indebtedness, including amounts owing to related parties, corporate awareness, product inventory, and general working capital purposes.

All securities issued under the Second Tranche of the Private Placement are subject to a statutory hold period expiring on September 7, 2026, in accordance with applicable securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act of 1933, as amended (the "1933 Act"), or under any U.S. state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act and applicable state securities laws.

About Vanta Holdings Inc.

Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC; WKN:A4205J) is a consumer health sciences company and the parent of the Vanta premium hydration and longevity brand. The Company develops, manufactures, and distributes functionally formulated beverages and nutraceutical products designed to support cellular function, mitochondrial energy, and metabolic performance. Through its Vanta brand and select private-label partnerships, the Company formulates alkaline and mineral-enriched ready-to-drink beverages, including its flagship Blackwater, alongside performance-oriented nutraceutical supplements featuring bioactive compounds and trace mineral complexes. Vanta's strategy focuses on building premium, science-driven functional hydration and nutraceutical brands supported by scalable manufacturing and distribution capabilities. The Company operates an integrated platform spanning product formulation, in-house research and development, manufacturing, brand development, and multi-channel distribution across domestic and international markets. This includes ownership of a natural alkaline spring water aquifer and a 40,000-square-foot, Health Canada and HACCP-certified manufacturing facility in the mountains of British Columbia. Vanta distributes its products through a diversified approach, including retail, direct-to-consumer e-commerce, and strategic distribution partnerships.

On behalf of the Board of Directors:

Martino Ciambrelli, Director
info@vantablackwater.com
604-569-1414

Disclaimer for Forward-Looking Information

This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements in this release include, but are not limited to, statements relating to: the intended use of proceeds of the Private Placement. Forward-looking information is based on management's current expectations, estimates, assumptions, and projections as of the date of this news release. Such information is subject to a number of known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, without limitation: the Company's ability to utilize the proceeds of the Private Placement as intended; and general economic, financial, and capital market conditions. Forward-looking information is not a guarantee of future performance and reflects management's expectations only as of the date hereof. There can be no assurance that the Company will achieve its intended use of proceeds described herein. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on forward-looking information.

SOURCE: Vanta Holdings Inc.



View the original press release on ACCESS Newswire

FAQ

What did Vanta (VNTXF) announce on May 6, 2026 regarding financing?

Vanta closed the second tranche of a private placement, issuing 615,000 units at $1.00. According to the company, this tranche raised $615,000 and brings the total aggregate gross proceeds of the placement to $1,000,000 for corporate use.

What are the warrant terms in Vanta's (VNTXF) May 6, 2026 private placement?

Each unit includes one warrant exercisable at $1.25 until May 6, 2028. According to the company, each warrant converts into one common share if exercised before the expiry date, potentially increasing outstanding shares.

How does Vanta (VNTXF) plan to use the net proceeds from the private placement?

Net proceeds are intended to pay outstanding and future payables, boost corporate awareness, replenish product inventory, and support general working capital. According to the company, related‑party amounts are included among items to be paid.

When do securities issued in Vanta's (VNTXF) second tranche become tradable?

Securities are subject to a statutory hold period expiring September 7, 2026. According to the company, the hold period is applied in accordance with applicable securities laws and restricts resale until that date.

How much capital did Vanta (VNTXF) raise in the second tranche on May 6, 2026?

The company raised $615,000 in the second tranche by issuing 615,000 units at $1.00 each. According to the company, this closes the second tranche and increases the placement's aggregate gross proceeds to $1,000,000.